Integrin α6-targeted SPECT Imaging of Breast Cancer
Clinical trial NCT04289532 · COMPLETED
Trial details
- NCT number
- NCT04289532
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-08
- Primary completion
- 2019-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.